Cargando…

Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome

BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism, ovarian dysfunction and polycystic ovarian morphology. Gut microbiota dysbiosis and metabolite are associated with PCOS clinical parameters. Yulin Tong Bu formula (YLTB), a traditional Ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Ya-Nan, Wang, Mei-Jiao, Yang, Jun-Pu, Wu, Xiang-Lu, Xia, Min, Bao, Mei-Hua, Ding, Yu-Bin, Feng, Qian, Fu, Li-Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939769/ https://www.ncbi.nlm.nih.gov/pubmed/36814581 http://dx.doi.org/10.3389/fendo.2023.1122709

Ejemplares similares

Corrigendum: Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome
por: Su, Ya-Nan, et al.
Publicado: (2023)

Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome
por: Wang, Yang, et al.
Publicado: (2022)

Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
por: Zhou, Ling, et al.
Publicado: (2020)

Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota
por: Zhang, Mingmin, et al.
Publicado: (2022)

Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome
por: Lin, Wei, et al.
Publicado: (2021)

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study
por: Sun, Shuliu, et al.
Publicado: (2020)

Investigation of the Mechanisms and Experimental Verification of Yulin Formula in the Treatment of Diminished Ovarian Reserve via Network Pharmacology
por: Wang, Ruye, et al.
Publicado: (2023)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome via regulating butyrate dependent gut–brain–ovary axis mechanism
por: Feng, Xueping, et al.
Publicado: (2022)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Editorial: Epigenetics of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2023)

Editorial: Gut microbiota and gut-associated metabolites in bone health
por: Srivastava, Rupesh K., et al.
Publicado: (2023)

The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome
por: Zhou, Hong, et al.
Publicado: (2022)

Effects of intestinal flora on polycystic ovary syndrome
por: Liu, Jiayue, et al.
Publicado: (2023)

Association between Polycystic Ovary Syndrome and Gut Microbiota
por: Guo, Yanjie, et al.
Publicado: (2016)

Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
por: Suturina, Larisa, et al.
Publicado: (2022)

Roles of gut microbiota and metabolites in overweight and obesity of children
por: Zhang, Shengan, et al.
Publicado: (2022)

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
por: Wang, Yishu, et al.
Publicado: (2022)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

The relationships between the gut microbiota and its metabolites with thyroid diseases
por: Jiang, Wen, et al.
Publicado: (2022)

Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome
por: Tseng, Ping-Huei, et al.
Publicado: (2021)

Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review
por: He, Fang-fang, et al.
Publicado: (2020)

Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: a retrospective cohort study
por: Pan, Xiaoming, et al.
Publicado: (2022)

Personality and Psychiatric Disorders in Women Affected by Polycystic Ovary Syndrome
por: Scaruffi, Elisabetta, et al.
Publicado: (2014)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
por: Yumiceba, Verónica, et al.
Publicado: (2020)

Neck Circumference Is Associated With Hyperuricemia in Women With Polycystic Ovary Syndrome
por: Yang, Haiyan, et al.
Publicado: (2021)

Comprehensive Assessment of the STIMs and Orais Expression in Polycystic Ovary Syndrome
por: Song, Tian, et al.
Publicado: (2022)

Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
por: Xu, Yue, et al.
Publicado: (2022)

Roles of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome
por: Koike, Hiroshi, et al.
Publicado: (2023)

Bidirectional association between polycystic ovary syndrome and periodontal diseases
por: Dou, Yang, et al.
Publicado: (2023)

Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
por: Mills, Edouard G., et al.
Publicado: (2023)

Editorial: Polycystic ovary syndrome: mechanism and management—volume II
por: Wang, Yishu, et al.
Publicado: (2023)

Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
por: Wang, Kexin, et al.
Publicado: (2023)

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
por: Wang, Dongmei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2nut1fei7vnjtpogfgsalpgld